A logarithmic-ratio microbiological assay has been developed for the estimation of concentrations of actinobolin (or inhibitory equivalents) in human saliva. The utility of this assay has been demonstrated by presenting data that show concentrations of this antibiotic (or inhibitory equivalents) detected in saliva or saline after incubation at 37 C for periods as long as 6 hr. The results of some statistical analyses of the assay data have been included.
A logarithmic-ratio microbiological assay has been developed for the estimation of concentrations of actinobolin (or inhibitory equivalents) in human saliva. The utility of this assay has been demonstrated by presenting data that show concentrations of this antibiotic (or inhibitory equivalents) detected in saliva or saline after incubation at 37 C for periods as long as 6 hr. The results of some statistical analyses of the assay data have been included.
Actinobolin, an antibiotic isolated from cultures of Streptomyces griseoviridis var. atrofaciens (T. H. Haskell et al., U.S. Patent 3,043,830, 1962) , has been reported to be strongly and somewhat specifically inhibitory in vitro for cariogenic streptococci (5) and to have strong cariostatic activity in vivo (D. E. Hunt et al., Abstr. 48th Genl. Mtg. Int. Ass. Dent. Res., New York, 1970) . Additionally, actinobolin has various chemical, biochemical, and pharmacological properties that appear to make it uniquely suited as an orally applied cariostatic antibiotic.
A microbiological assay was developed for actinobolin because of the need of an assay for clinical dental trials which are planned and because no microbiological assay which uses a cariogenic streptococcal strain is presently available for this cariostatic antibiotic. This report describes a logarithmic-ratio microbiological assay for the determination of actinobolin concentrations (or inhibitory equivalents) in human saliva. (3) . A 5-ml amount of the inoculated agar was added to the previously described plates containing 8 ml of congealed sterile agar. Stock solutions of actinobolin were prepared in sterile saline and in pooled, human saliva (heated to 70 C for 20 min) so that when 0.08 ml of the various solutions was added to paper discs (1.27 cm in diameter, no. 740-E, Schleicher and Schuell Co., Keene, N.H.), the following concentrations (micrograms of actinobolin per disc) were obtained: 6, 8, 12, 16, 24, 32, 48, 64, 96, and 128. These discs, used for the preparation of standard assay curves together with discs charged with experimental samples, were prepared in duplicate. The reported experiments were repeated three times on successive days. To insure clearly defined zones of inhibition, no more than five discs were placed on each assay plate. All plates were incubated anaerobically for 14 to 16 hr at 37 C. The resulting zones of growth inhibition were measured and were then plotted on semilogarithmic graph paper with drug concentrations per disc on the logarithmic scale and zone diameters on the arithmetic scale. HUNT, BRADLEY, able), of antibiotic. Thus, Y and X are assumed to satisfy the equation Y = a + f3X + c, where e is a random variable with expectation of zero and variance of a2. The method of least squares was used to obtain estimates of a, ,B, and a-for the saline and saliva standard curves. The averages of the indexes of precision (X) were 0.06 and 0.09 for the saline and saliva standard curves, respectively, where X equals the standard deviation of points from the fitted line/the estimated slope of the line. The slope of all standard curves was found to be highly significant (P < 0.001). A test for nonlinearity between diameters of zones of inhibition and logarithmic concentrations of actinobolin revealed no significant deviation with the saline standard curves. Two of three saliva standard curves, however, showed statistically significant deviation from linearity. Since this was attributable mainly to a possible curvilinear effect at very high and very low antibiotic concentrations and since there was limited scatter of points around the curves, the deviation from linearity was found to be of no practical importance. A further measure of the accuracy of the assay is shown in Table 2 , in which known concentrations of actinobolin are compared with their estimates obtained from the standard curves. The confidence limits in Table 2 are calculated from the anti-logarithms of the fiducial limits for the logarithmic concentrations of actinobolin. Fiducial limits are commonly used for establishing limits on estimates of independent variables when values of the dependent variables are observed (2) . These limits show the range that should contain the known concentrations 95% of the time. With known concentrations of antibiotic dissolved in saline, only 1 of the 12 calculated confidence intervals failed to show the known concentration of antibiotic. With known concentrations of antibiotic dissolved in saliva, 3 (25%) of the 12 calculated confidence limits did not contain the known concentration of actinobolin. This is higher than the expected 5 % and can probably be attributed to the failure of s, the estimate of a-, to reflect all sources of variation, i.e., ions in saliva AND BACHMANN APPL. MICROBIOL.
MATERIALS AND METHODS
which have been reported (8) to antagonize the inhibitor activity of actinobolin. Additionally, estimates within each experiment are correlated, thus the true confidence level may be less than 95%. The concentrations of actinobolin detected in saline or pooled saliva, which had been incubated at 37 C for periods as long as 6 hr, are shown in Fig. 2 . These data show that actinobolin dissolved in saline or saliva essentially retained its full inhibitory activity for 4 hr. At the end of 6 hr, some degradation of actinobolin occurred in saliva. In microbiological assays, it is assumed that the product assayed in the experimental samples differs only from the standard antibiotic solution by some dilution factor. Consequently, dilutions of experimental samples, when assayed, should yield points that parallel the standard curve in a logarithmic-ratio assay (1). The data presented in Fig. 3 
